Dr. Gillies Lab
Dr. Gillies Grants and Patents
Patents
13MB047PRWOUS
Systems, Methods, and Devices for Analyzing Quantitative Information Obtained from Radiological Images
August 1, 2017
11MA026PRWOUS
Method of Screening for Colon Cancer Using Biomarkers
November 8, 2016
10MB069PRWOUS
Melanocortin 1 Receptor Ligands and Methods of Use
September 13, 2016
11MA035PRWOUS
Transient Hypoxia Inducers and Their Use
August 2, 2016
6,596,258:
Method of obtaining extracellular and intracellular pH images and spectra by magnetic resonance using extrinsic indicators containing 1H or 19F, July 22, 2003
Provisional Docketed:
Hyperpolarized deutero 3-APP imaging agent
Provisional Docketed:
Combination of TH-302 with a vasodilators (or a pH buffer)
Provisional, Number UA07-022:
Cell Surface Targets for the Development of Diagnostic, Imaging and Therapeutic Agents for Pancreatic Cancer
Provisional Docketed 080902-79 & 080903-79, 2008:
Method of Identifying pancreatic cancer cells
Invention Disclosure Docketed 09MB048:
Non-volatile buffers as inhibitors of metastasis and cancer spread
Invention Disclosure Docketed 10MA024:
Targeted method for non-invasive detection of breast cancer in lymph nodes
Provisional Application Docketed 10MA024PR2:
Non-invasive Detection of Breast Cancer Lymph Node Metastasis using Carbonic Anhydrases IX and XII Targeted Imaging Probes
Provisional, Docketed 11MA026PR:
Identification and validation of surrogate markers for colon adenoma and adenocarcinoma
Provisional Docketed 10MB069PR:
Melanocortin 1 Receptor Ligand-Micelle Complexes and Methods of Use
61/478,465:
Transient Hypoxia Inducers and Their Use
13/479,638:
Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion
60/401,212:
Multivalent Constructs for Use in Biomarker Imaging
13/813,605:
Molecular Imaging of Cancer Cells in vivo
61/618,144:
Molecular Imaging Probe and Method of Melanoma Detection Using Targeted Molecular Imaging Agents
61/644,828:
Molecular Imaging Probes for Lung Cancer Intraoperative Guidance
14/117,949:
Melanocortin 1 Receptor Ligands and Methods of Use
14/041,296:
Method of Screening for Colon Cancer Using Biomarkers
14/112,906:
Transient Hypoxia Inducers and Their Use
14/240,305:
Molecular Imaging of Cancer Cells in Vivo
61/754,140:
Quantitative Predictors of Survival in Lung Adenocarcinoma
60/865,544:
Systems, Methods and Devices for Analyzing Quantitative Information Obtained from Radiological Images
61/890,217:
Systems and Methods for Diagnosing Tumors in a Subject by Performing a Quantitative Analysis of Texture-Based Features of a Tumor Object in a Radiological Image
Grants
Florida Department of Health, Bankhead-Coley Cancer Research Program
21B12
(PI: Schabath)
06/02/2021 - 05/31/2026
Non-invasive radiomic biomarkers to predict treatment response for immunotherapy of lung cancer
NIH/NCI
R01CA248016-01A1
(PI: Gillies, Niell)
05/01/2021 - 04/30/2026
Radiomics and Pathomics to predict upstaging of DCIS
NIH/NCI
R01CA239219
(PI: Gillies, Pilon-Thomas)
02/01/2020 – 01/31/2025
Imaging Acidosis and Immune Therapy in PDAC
NIH/NCI
P30CA076292
(PI: Sellers)
02/01/2012 – 01/31/2022
Moffitt Cancer Center Support Grant
NIH/NCI
U54CA193489 Cost Extension
(PI: Gatenby, Gillies, Anderson)
09/01/2020 – 08/31/2021
The eco-evolutionary dynamics of small metastatic population in treatment strategies for prevention and cure
NIH/NCI
U01CA143062
(PI: Gillies, Schabath)
12/21/2016 – 07/31/2021
Radiomics of NSCLC
NIH/NCI
U01CA202958
(PI: Basanta, Lynch, [Gillies Co-Investigator])
06/08/2016 - 05/31/2021
“Multi-Scale Modeling of Bone Environment Responses to Metastatic Prostate Cancer”
NIH/NCI
U01CA200464
(PI: Lee, Gillies, Heine, Schabath)
11/07/2016 – 03/31/2021
Moffitt Imaging Biomarker Validation Center
NIH/NCI
U54CA193489
(PI: Gatenby, Gillies, Anderson)
09/23/2015 – 08/31/2020
Cancer as a complex adaptive system
NIH/NCI
R01CA187532
(PI: Gillies, Martinez)
04/01/2015 – 03/31/2020
Imaging Habitats in Sarcoma
Florida Department of Health, Bankhead-Coley Cancer Research Program
8BC04
(PI: Gillies, Pillai)
2018-2020
"Targeting the lipogenic phenotype induced by extracellular acidosis in breast cancer"
NIH/NCI
R01CA077575
(PI: Gillies)
07/01/1999 – 07/31/2019
Causes and Consequences of Acid pH in Tumors
NIH/NCI
R01CA190105
(PI: Gillies)
09/19/2014 – 08/31/2018
(PQC4) Habitats in Prostate Cancer
V Foundation for Cancer Research - Project D2016-004
(PI: Gatenby, [Gillies Co-Investigator])
02/01/2016 – 01/31/2018
Combining targeted therapy and immunotherapy as an evolutionary double bind to optimize treatment in esophageal cancer
Gillies & Gatenby subcontracts
NIH/NCI
U01CA196405
(PI: Massion)
09/24/2015 – 08/31/2020
Cellular, Molecular and Quantitative Imaging Analysis of Screening-Detected Lung Adenocarcinoma
Gillies’ Role: PI, Moffitt subcontract
NIH/NCI
U01CA186145
(PI: Massion)
08/03/2015 – 07/31/2020
Non-invasive evaluation of indeterminate pulmonary nodules
Gillies’ Role: PI, Moffitt subcontract
NIH/NCI
U24CA180927
(PI: Rosen)
09/01/2014 – 08/31/2019
Informatics Tools for Optimized Imaging Biomarkers for Cancer Research & Discovery
Gillies’ Role: PI, Moffitt subcontract
NIH/NCI
R01CA189295
(PI: Pollack)
08/01/2014 - 07/31/2019
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis
Gillies’ Role: PI, Moffitt subcontract